Home
Bioiberica

Bioiberica Market Share Analysis for August 2026

El segmento Hip & Joint Health supera los 264 M$ globalmente. Descubre por qué el colágeno nativo tipo II (Collavant® n2) crece a una CAGR del 6,9% hasta 2030.

Health > Health - Other

Domainbioiberica.com

Year Founded1975

Employees201 - 500

Annual Revenue$50M - $75M

Bioiberica

Bioiberica (including company regionals)

bioiberica.com

See more website traffic and engagement information

Bioiberica Revenue up to August 2026 is 50M - 75M

revenue generated by Bioiberica top domains

Bioiberica top domains revenue over 3 years

Revenue for Bioiberica top domains

bioiberica.com50M - 75M

See more with Sales Intelligence

Total visits to Bioiberica's top domains

Understand Bioiberica market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

bioiberica.com25.6K

See more with Sales Intelligence

Avg. visit duration in Bioiberica's top domains

Analyze Bioiberica engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

bioiberica.com00:00:46

See more with Sales Intelligence

Avg. pageviews on Bioiberica's top domains

See how Bioiberica keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

bioiberica.com2.33

See more with Sales Intelligence

Bioiberica top competitors by domain

Top similar sites in August 2026, ranked by their affinity

btsa.comCompany NameBTSAEmployees51 - 200HQSpain, Alcalá De HenaresAnnual revenue$15M - $25MTotal visits33.2KScience and Education > Science and Education - Other

Top technologies used by Bioiberica

These are the website technologies, by industry, used by Bioiberica top domains

Advertising (8)

DoubleClick

Conversion & Analytics (7)

Google Analytics

Widget (7)

reCAPTCHA

Social (5)

Facebook Connect

More Technologies

8

See all

News & Signals from Bioiberica

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBioiberica partners with Ryusendo Co..Bioiberica, a global life science company, has announced the launch of its native (undenatured) type II collagen ingredient for joint health, Collavant(R) n2, to the Japanese nutraceuticals market, made possible through a strategic partnership with local distributor Ryusendo Co., Ltd.

NewsBioiberica launches Collavant n2.* Bioiberica has partnered with distributor Ryusendo to launch its joint health ingredient, Collavant n2, in Japan.

NewsBioiberica launched DAOgest on Jul 1st '24.* Bioiberica S.A.U. (Spain) launched DAOgest in July 2024, a clinically validated branded ingredient designed specifically to break down dietary histamine before it enters the bloodstream.